CEACAM5 and neoplasm: The proportions of the above tumor markers in each group were: 31.6%, 11.0% and 9.4% for CA125; 48.4%, 26.7% and 23.1% for CA724; 21.0%, 23.5% and 18.5% for CA199; and 4.2%, 39.2% and 43.2% for CEA.